Ichor Biologics Private Limited — Immunoglobulin Exporter Profile
Indian Pharmaceutical Exporter · #6 for Immunoglobulin · $1.5M export value · DGFT Verified
Ichor Biologics Private Limited is the #6 Indian exporter of Immunoglobulin with $1.5M in export value and 30 verified shipments. Ichor Biologics Private Limited holds a 1.6% market share in Immunoglobulin exports across 8 countries.
Ichor Biologics Private Limited — Immunoglobulin Export Profile: Buyers & Destinations

Where Does Ichor Biologics Private Limited Export Immunoglobulin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MOROCCO | $209.8K | 5 | 21.8% |
| VIETNAM | $200.0K | 4 | 20.8% |
| COLOMBIA | $172.7K | 4 | 18.0% |
| VIETNAM, DEMOCRATIC REP. OF | $150.0K | 3 | 15.6% |
| NEPAL | $127.9K | 3 | 13.3% |
| SRI LANKA | $50.0K | 2 | 5.2% |
| COSTA RICA | $50.0K | 1 | 5.2% |
| DOMINICAN REPULIC | $455 | 1 | 0.0% |
| GERMANY | $277 | 7 | 0.0% |
Ichor Biologics Private Limited exports Immunoglobulin to 9 countries. The largest destination is MOROCCO accounting for 21.8% of Ichor Biologics Private Limited's Immunoglobulin shipments, followed by VIETNAM (20.8%) and COLOMBIA (18.0%). These destinations reflect Ichor Biologics Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Immunoglobulin from Ichor Biologics Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CENTRAL PHARMACEUTICAL CPC1 JSC | VIETNAM | $250.0K | 5 |
| PHARMAPROM | MOROCCO | $159.8K | 4 |
| DIVINE DRUG DISTRIBUTORS PVT LTD | NEPAL | $127.9K | 3 |
| CENTRAL PHARMACEUTICAL | VIETNAM | $100.0K | 2 |
| BLAU FARMACEUTICA COLOMBIA S.A.S | COLOMBIA | $100.0K | 2 |
| LABORATORIOS MINTLAB SAS | COLOMBIA | $72.7K | 2 |
| PHARMA ASSOCIATES | SRI LANKA | $50.0K | 2 |
| PHARMAPROM ROUTE D | MOROCCO | $50.0K | 1 |
| PROFILE DE TABACA S.A. | COSTA RICA | $50.0K | 1 |
| MANUEL TOVAR | DOMINICAN REPULIC | $455 | 1 |
Ichor Biologics Private Limited supplies Immunoglobulin to 11 buyers globally. The largest buyer is CENTRAL PHARMACEUTICAL CPC1 JSC (VIETNAM), followed by PHARMAPROM (MOROCCO) and DIVINE DRUG DISTRIBUTORS PVT LTD (NEPAL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Immunoglobulin Export Value and How Much Does Ichor Biologics Private Limited Contribute?
India exported $39.9M worth of Immunoglobulin through 1,841 shipments from 197 suppliers to 119 countries, serving 570 buyers globally. Ichor Biologics Private Limited contributes $1.5M to this total, accounting for 1.6% of India's Immunoglobulin exports. Ichor Biologics Private Limited ships Immunoglobulin to 9 countries through 11 buyers.
What Is the Average Shipment Value for Ichor Biologics Private Limited's Immunoglobulin Exports?
Ichor Biologics Private Limited's average Immunoglobulin shipment value is $50.0K per consignment, based on 30 shipments totaling $1.5M. The largest destination is MOROCCO (21.8% of Ichor Biologics Private Limited's Immunoglobulin exports).
How Does Ichor Biologics Private Limited Compare to Other Indian Immunoglobulin Exporters?
Ichor Biologics Private Limited ranks #6 among 197 Indian Immunoglobulin exporters with a 1.6% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($16.4M), RELIANCE LIFE SCIENCES PRIVATE LIMITED ($14.3M), ICHOR BIOLOGICS PRIVATE LIMITED ($1.5M). Ichor Biologics Private Limited processed 30 shipments to 8 destination countries.
What Immunoglobulin Formulations Does Ichor Biologics Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| IMMUGLO NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P - 100 ML | $100.0K | 2 |
| IMMUGLO (NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P-100 ML) | $100.0K | 2 |
| IMMUGLO-(HUMAN NORMAL IMMUNOGLOBULIN FORINTRAVENOUS USE 5% I.P-100 ML) | $87.9K | 2 |
| IMMUGLO NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5 B P 100ML | $59.8K | 2 |
| IMMUGLO(NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P-100 ML)(QTY: 2000 VIALS) | $50.0K | 1 |
| IMMUGLO(NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P-100 ML)(QTY: 3000 VIALS) | $50.0K | 1 |
| IMMUGLO(NORMAL IMMUNOGLOBULIN FOR INTRAV | $50.0K | 1 |
| IMMUGLO NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE B.P. 5% VIAL 100ML PACK 1S | $50.0K | 1 |
| IMMUGLO(NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P-100ML)NOS | $50.0K | 1 |
| IMMUGLO (NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P - 100 ML) (QTY 7500 VIALS) | $50.0K | 1 |
Ichor Biologics Private Limited exports 22 distinct Immunoglobulin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IMMUGLO NORMAL IMMUNOGLOBULIN FOR INTRAVENOUS USE 5% B.P - 1 with 2 shipments worth $100.0K.
How Does Ichor Biologics Private Limited Compare to Nearest Immunoglobulin Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | BHARAT SERUMS AND VACCINES LIMITED | $16.4M | 329 | 44 | $50.0K |
| 1 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | $14.3M | 286 | 27 | $50.0K |
| 6 | ICHOR BIOLOGICS PRIVATE LIMITED ★ | $1.5M | 30 | 8 | $50.0K |
| 9 | VIRCHOW BIOTECH PRIVATE LIMITED | $1.0M | 20 | 3 | $50.0K |
| 7 | CHANDRA BHAGAT PHARMA LIMITED | $950.0K | 19 | 2 | $50.0K |
Ichor Biologics Private Limited ranks #6 among 197 Indian Immunoglobulin exporters. Average shipment value of $50.0K compared to the market average of $202.5K. The closest competitors by value are BHARAT SERUMS AND VACCINES LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Immunoglobulin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 542 | 29.4% |
| SAHAR AIR | 518 | 28.1% |
| Bombay Air | 210 | 11.4% |
| Bombay Air Cargo | 63 | 3.4% |
| HYDERABAD AIR | 52 | 2.8% |
| DELHI AIR CARGO ACC (INDEL4) | 47 | 2.6% |
| HYDERABAD ACC (INHYD4) | 40 | 2.2% |
| DELHI AIR | 37 | 2.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Immunoglobulin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Immunoglobulin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ichor Biologics Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 30 individual customs records matching Ichor Biologics Private Limited exporting Immunoglobulin, covering 22 formulations to 9 countries via 11 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 570+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Immunoglobulin Export Data from Ichor Biologics Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ichor Biologics Private Limited's Immunoglobulin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ichor Biologics Private Limited
Company Profile
0 products · $0 total trade · 0 categories
Immunoglobulin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ichor Biologics Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Immunoglobulin. For current shipment-level data, contact TransData Nexus.